Recombivax Hb
Payments companies reported to CMS as associated with Recombivax Hb. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Recombivax Hb, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Recombivax Hb
These are the largest totals companies reported as associated with Recombivax Hb. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Catherine Mccarthy | Reno, NV | Family Medicine | $2,600.31 |
| Craig Levoy | Bentonville, AR | Family Medicine | $1,907.05 |
| Alexander Hamling | Bothell, WA | Pediatrics | $1,744.82 |
| Warren Seigel | Brooklyn, NY | Pediatrics | $1,697.67 |
| Leonard Krilov | Mineola, NY | Pediatric Infectious Diseases | $1,690.67 |
| Anita Chandra Puri | Chicago, IL | Pediatrics | $1,458.86 |
| Natasha Burgert | Kansas City, MO | Pediatrics | $1,336.40 |
| Cuong Ngo | Denver, CO | Family Medicine | $55.85 |
| Hue Vo | Denver, CO | Family Medicine | $55.85 |
| Jianwen Wu | Chandler, AZ | Internal Medicine | $45.76 |
Prescribed Recombivax Hb?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.